POINT Biopharma Global Balance Sheet Health
Financial Health criteria checks 6/6
POINT Biopharma Global has a total shareholder equity of $424.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $477.7M and $53.5M respectively. POINT Biopharma Global's EBIT is $107.8M making its interest coverage ratio -7.1. It has cash and short-term investments of $339.2M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -7.1x |
| Cash | US$339.16m |
| Equity | US$424.19m |
| Total liabilities | US$53.51m |
| Total assets | US$477.70m |
Recent financial health updates
Recent updates
POINT Biopharma Global Inc. (NASDAQ:PNT) Analysts Just Slashed This Year's Estimates
Aug 20
We Think POINT Biopharma Global (NASDAQ:PNT) Can Easily Afford To Drive Business Growth
Feb 01A Look At The Fair Value Of POINT Biopharma Global Inc. (NASDAQ:PNT)
Oct 18Point Biopharma plummets on announcing common stock offering
Sep 13POINT Biopharma Global GAAP EPS of -$0.27 misses by $0.05
Aug 12Financial Position Analysis
Short Term Liabilities: PNT's short term assets ($353.2M) exceed its short term liabilities ($38.7M).
Long Term Liabilities: PNT's short term assets ($353.2M) exceed its long term liabilities ($14.8M).
Debt to Equity History and Analysis
Debt Level: PNT is debt free.
Reducing Debt: PNT had no debt 5 years ago.
Debt Coverage: PNT has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PNT has no debt, therefore coverage of interest payments is not a concern.